Zobrazeno 1 - 10
of 131
pro vyhledávání: '"Giorgio Dini"'
Autor:
Adriana Balduzzi, Paola De Lorenzo, André Schrauder, Valentino Conter, Cornelio Uderzo, Christina Peters, Thomas Klingebiel, Jan Stary, Maria S. Felice, Edina Magyarosy, Martin Schrappe, Giorgio Dini, Helmut Gadner, Maria Grazia Valsecchi
Publikováno v:
Haematologica, Vol 93, Iss 6 (2008)
The advantage of allogeneic transplant from compatible related donors versus chemotherapy in children with very-high-risk acute lymphoblastic leukemia in first complete remission was previously demonstrated in an international prospective trial. This
Externí odkaz:
https://doaj.org/article/938acc474e1a4f6dad4e61c6f5d982a1
Publikováno v:
Hematology Reports, Vol 2, Iss 1 (2010)
XXXVI Italian Congress of AIEOP (Associazione Italiana Ematologia Oncologia Pediatrica - Pisa, Italy, 6-8 June 2010
Externí odkaz:
https://doaj.org/article/6d61b72d13f142b7baa569becafe8178
Autor:
Taner Demirer, Ruth Ladenstein, Alois Gratwohl, Alvaro Urbano-Ispizua, Giorgio Dini, Giovanni Rosti, H Baldomero
Background: Hematopoetic stem cell transplants (HSCT) are discussed as treatment options for patients with solid tumors. Transplant numbers have changed substantially over the last decade, few controlled studies are available and different opinions p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cd44a097ee51d1947dabcdbcb932c0f9
http://doc.rero.ch/record/302838/files/mdh142.pdf
http://doc.rero.ch/record/302838/files/mdh142.pdf
Autor:
L. Garbarino, Stefano Giardino, Erika Biral, Giorgio Dini, Maura Faraci, Edoardo Lanino, Giuseppe Morreale, Elio Castagnola, Ilaria Caviglia
Publikováno v:
Pediatric Transplantation. 16:887-893
a-GvHD may complicate allogeneic HSCT. In this retrospective single-center study, we evaluated incidence and risk factors of a-GvHD in 197 consecutive allogeneic pediatric HSCTs applying Glucksberg and NIH a-GvHD classifications. Among 179 eligible t
Publikováno v:
OCEANS 2016 MTS/IEEE Monterey.
After the positive experiences collected in the period 2012–2015, Nemo's Garden Project has been started again in 2016 trying to improve the knowledge not only about the engineering and installation underwater of structures dedicated to the growth
Autor:
Christina Peters, Claudio Giardini, Akif Yesilipek, Sara Marktel, Ulrike Pötschger, A. A. Hussein, Ali Al-Ahmari, Federica Pilo, Clara Targhetta, A. Ghavamzadeh, Franco Locatelli, Emanuele Angelucci, J de la Fuente, Donatella Baronciani, Maria Grazia Orofino, Giorgio Dini, Marco Zecca, Javid Gaziev, Peter Bader
Allogeneic hemopoietic stem cell transplantation (HSCT) is the only method currently available to cure transfusion-dependent thalassemia major that has been widely used worldwide. To verify transplantation distribution, demography, activity, policies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d663f6d801f4b7ee17ddd0d6ce4693f1
http://hdl.handle.net/11573/1487564
http://hdl.handle.net/11573/1487564
Autor:
Jerry Stein, Johan Arvidson, Anne O'Meara, A. Schulz, Joseph M. Massaro, Paul G. Schlegel, Ralph B. D'Agostino, Jacek Winiarski, Annette Hewitt, Petr Sedlacek, Attilio Rovelli, Klaus-Michael Debatin, Christina Peters, Margaret Hoyle, Jacek Toporski, Peter Bader, Simone Cesaro, Giorgio Dini, Monika Führer, Ingo Müller, Jaap Jan Boelens, Massimo Iacobelli, Maura Faraci, Anders Fasth, André Schrauder, Christine Mauz-Körholz, Susanne Matthes-Martin, Hulya Ozsahin, Robert Wynn, Johanna Schrum, Dominique Valteau-Couanet, Karoline Ehlert, Karl Walter Sykora, Bernd Gruhn, Johann Greil, Selim Corbacioglu
Publikováno v:
The Lancet, Vol. 379, No 9823 (2012) pp. 1301-9
Hepatic veno-occlusive disease is a leading cause of morbidity and mortality after haemopoietic stem-cell transplantation (HSCT). We aimed to assess whether defibrotide can reduce the incidence of veno-occlusive disease in this setting.In our phase 3
Autor:
André Tichelli, Helen Baldomero, Giorgio Dini, Jane F. Apperley, Jakob Passweg, Vanderson Rocha, Anna Sureda, Marrow Transplantation, Martin Stern, Theo de Witte, Alois Gratwohl, Dietger Niederwieser, Ronald Brand
Publikováno v:
Cancer, Vol. 115, No 20 (2009) pp. 4715-4726
CANCER
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Cancer, 115, 4715-26
Cancer, 115, 20, pp. 4715-26
CANCER
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
instname
Cancer, 115, 4715-26
Cancer, 115, 20, pp. 4715-26
Contains fulltext : 81638.pdf (Publisher’s version ) (Closed access) BACKGROUND: It was investigated whether the European Group for Blood and Marrow Transplantation risk score, previously established for chronic myeloid leukemia, could be used to p
Publikováno v:
Bone Marrow Transplantation. 41:S65-S70
GvHD remains a source of significant morbidity and mortality in the setting of allogeneic haematopoietic SCT. Improving outcomes in stem cell transplant recipients requires additional therapeutic modalities for GvHD, especially for patients who fail